Arena Pharmaceuticals Inc. was acquired by Pfizer in March 2022. ARNA no longer trades, so its trials are no longer stock catalysts and are left off the trial calendar. The records below are kept for reference; the programs now belong to Pfizer, and their dates may not have been updated since.
Clinical trial readout dates for Arena Pharmaceuticals Inc., compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
In progress, no date published
Phase 2aSENS-401
Cisplatin-Induced Ototoxicity
date not published
Ongoing
Discussion
No messages yet. If you follow ARNA, you can start the conversation.